Navigation Links
SFC Fluidics, Inc. Receives SBIR Phase II Funding for Development of an Implantable Drug Delivery Device
Date:8/30/2017

SFC Fluidics® is very pleased to announce it has received $1.4 million in Phase II Small Business Innovation Research funding from the National Institutes of Health for the development of an implantable, wirelessly controlled, rapid dosing drug delivery system for small animal research. The min-ePump™ implantable drug delivery device will allow real-time, remote controlled delivery of drugs and therapeutics to animal models for addiction and behavior research studies. This system will allow for improved testing methods, as currently animals are required to be tethered to a pump and tested in isolation.

Key research areas that can benefit from untethered animal behavior models include substance abuse, mood disorders, schizophrenia, choice behavior, sleep behavior, stimulus response, relapse, anxiety, avoidance, PTSD, chronic stress, aggressive behavior, cognition, depression, Alzheimer’s disease, Parkinson’s disease, aging disorders, and management of chronic pain in humans. Additionally, the min-ePump™ will provide tremendous advantages for the development of a simple patch pump and artificial pancreas for people with diabetes. This technology will allow for miniaturization that will offer people with diabetes a new level of convenience and discretion to manage the disease.

SFC Fluidics, Inc. has a mission to advance healthcare and improve quality of life through our enabling microfluidic technologies. The company’s vision is to become a recognized global leader in the drug delivery and health monitoring markets where our unique product lines improve lifestyle and affordability. SFC Fluidics® is a VIC Technology Venture Development™ portfolio company.

Research reported in this release was supported by The National Institute on Drug Abuse of the National Institutes of Health under grant number [2R44DA041173-02]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Read the full story at http://www.prweb.com/releases/SFCFluidicsDeveloping/ImplantForDrugDelivery/prweb14639592.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Heidelberg Instruments receives orders for advanced VPG+ Volume Pattern Generator from two Asian based photomask suppliers
2. Worcester Polytechnic Institute Receives National Institutes of Health Funding to Develop a Heart Muscle Patch
3. Benchworks Receives Industry Accolades
4. Kibow Biotech Inc. (Buzz of Bio Winner, 2014) Receives US Patent for Gout/Hyperuricemia Product Formulation Based on Modulation of the Gut Microbiome With Probiotics and Prebiotics
5. Heidelberg Instruments receives order for an advanced VPG Large Area Volume Pattern Generator
6. G-CON Manufacturing CEO Receives Recognition as a Top Pharmaceutical Industry Influencer
7. Worcester Polytechnic Institute Receives $1.6 million NIH Award to Study Gender Differences in Neurobiology
8. Singota™ Solutions CEO Receives 2017 Distinguished Alumni Award
9. Prometic Receives $9.5 Million Purchase Order From Multinational Client
10. Intralytix Receives FDA Regulatory Clearance for Phage-Based Shigella Technology
11. Bactana Animal Health Receives Patent Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... CA, USA (PRWEB) , ... October 11, 2017 , ... ... to take place on 7th and 8th June 2018 in San Francisco, CA. The ... influencers as well as several distinguished CEOs, board directors and government officials from around ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh ... orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of ... SBT-100 is able to cross the cell membrane and bind intracellular STAT3 and ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program ... in Volunteer Experience from US2020. , US2020’s mission is to change the trajectory ...
Breaking Biology Technology:
(Date:5/16/2017)... , May 16, 2017  Veratad Technologies, LLC ( ... online age and identity verification solutions, announced today they ... Conference 2017, May 15 thru May 17, 2017, in ... and International Trade Center. Identity impacts ... and in today,s quickly evolving digital world, defining identity ...
(Date:4/18/2017)... , April 18, 2017  Socionext Inc., a global expert in ... media edge server, the M820, which features the company,s hybrid codec ... provided by Tera Probe, Inc., will be showcased during the upcoming ... NAB show at the Las Vegas Convention ... Click ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
Breaking Biology News(10 mins):